Skip to Content

Vaccinating Against Mutated RAS in Multiple Myeloma

At EHA 2024, Hanne Norseth, MD, PhD student, Oslo Myeloma Center, Norway, presents a study that aims to evaluate vaccinating against mutated RAS in multiple myeloma. In this MEDtalk, Hanne Norseth presents the tentative data of the ongoing study.

Hanne Norseth

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top